William D. Waddill, Senior Vice President and Chief Financial Officer of OncoMed Pharmaceuticals, highlights the importance of capital formation to encourage investment in the biotechnology industry and spur job growth. Mr. Waddill provided testimony today on behalf of BIO at a Senate Committee on Banking, Housing, and Urban Affairs hearing.
|
April 30, 2013
|
April 30, 2013
|
April 27, 2013
|
April 25, 2013
|
|
April 25, 2013
|
April 25, 2013
|
April 24, 2013
|
April 24, 2013
|